Position in JNJ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$521,243,122
+$92,027,374 QoQ
Shares Held
2,132,397
+2.8% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AVIVA PLC holds $4,673,816,581 across 10 Drug Manufacturers - General names. JNJ ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,087,661 | $2,186,708,502 | |
| 2 | LLY |
ELI LILLY & Co
|
712,581 | $655,410,626 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
2,132,397 | $521,243,122 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,236,573 | $389,327,366 | |
| 5 | ABBV |
AbbVie Inc.
|
1,531,018 | $332,981,104 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,174,576 | $163,700,657 | |
| 7 | AMGN |
Amgen Inc
|
464,183 | $163,322,788 | |
| 8 | PFE |
Pfizer Inc
|
4,849,934 | $136,186,146 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $521,243,122 | 2,132,397 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $429,215,748 | 2,074,007 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $354,419,575 | 1,911,442 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $275,146,283 | 1,801,285 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $279,069,581 | 1,682,764 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $209,834,798 | 1,450,939 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $247,827,499 | 1,529,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $218,289,375 | 1,493,496 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $196,107,984 | 1,239,699 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $190,397,250 | 1,214,733 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $171,614,072 | 1,101,856 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $196,585,455 | 1,187,684 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $148,257,500 | 956,500 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $173,926,940 | 984,585 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $134,300,379 | 822,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $152,839,127 | 861,017 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $130,833,667 | 738,214 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $146,717,158 | 857,644 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $151,668,041 | 939,121 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $166,432,867 | 1,010,276 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $163,715,278 | 996,138 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $153,322,427 | 974,218 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $143,678,428 | 965,062 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $140,663,749 | 1,000,240 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $136,417,160 | 1,040,320 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||